Morris Schambelan, MD
Professor of Medicine
Medicine
School of Medicine

Education & Training

Show all (1) Hide

• Residency School of Medicine University of California, San Francisco

Websites

Show all (1) Hide

• Profile at endocrine.medicine.ucsf.edu (endocrine.medicine.ucsf.edu)

Grants and Projects

Show all (9) Hide

• A Resource for Biomedical Mass Spectrometry, NIH, 1975-2014
• Uridine Supplementation, Mitochondrial Function, and Glucose Metabolism in HIV, NIH, 2006-2010
• Leptin Treatment of HIV-Associated Lipodystrophy, NIH, 2002-2008
• Can IGF-I/IGFBP-3 Reverse Central Fat Accumulation?, NIH, 2004-2008
• General Clinical Research Center, NIH, 1974-2007
• Anabolic Therapies and Their Metabolic Effects in Aids, NIH, 1992-2004
• Ergogenic Effects of Creatine Supp .in HIV-Assoc.Wasting, NIH, 2000-2004
• Mitigation of Episodic Wasting in Hiv Infection, NIH, 1997-2003
• Renin, Angiotensin, Steroids, Ions and Blood Pressure, NIH, 1977-1996

Publications (172)

Top publication keywords:
ReninKidneyHIV Wasting SyndromeAldosteroneHIV InfectionsAngiotensin IIHIV Protease InhibitorsInsulin-Like Growth Factor IRenin-Angiotensin SystemHuman Growth HormoneBody CompositionReceptors, AngiotensinGrowth HormoneAdipose TissueReceptor, Insulin

• Growth hormone receptor antagonism with pegvisomant in insulin resistant non-diabetic men: A phase II pilot study.
  F1000Research 2017 Lee AP, Mulligan K, Schambelan M, Murphy EJ, Weiss EJ
• Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat.
  The Journal of clinical endocrinology and metabolism 2015 Schwarz JM, Noworolski SM, Wen MJ, Dyachenko A, Prior JL, Weinberg ME, Herraiz LA, Tai VW, Bergeron N, Bersot TP, Rao MN, Schambelan M, Mulligan K
• Subchronic sleep restriction causes tissue-specific insulin resistance.
  The Journal of clinical endocrinology and metabolism 2015 Rao MN, Neylan TC, Grunfeld C, Mulligan K, Schambelan M, Schwarz JM
• Cutis Verticis Gyrata in Men Affected by HIV-Related Lipodystrophy.
  Dermatology research and practice 2013 Khanijow K, Unemori P, Leslie KS, Mulligan K, Schambelan M, Maurer T
• Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery.
  Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2013 Campos GM, Rabl C, Havel PJ, Rao M, Schwarz JM, Schambelan M, Mulligan K

Show all (167 more) Hide

• Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to parathyroid hormone.
  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2013 Park-Sigal J, Don BR, Porzig A, Recker R, Griswold V, Sebastian A, Duh QY, Portale AA, Shoback D, Schambelan M
• Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected Men.
  AIDS research and treatment 2012 Rao MN, Schambelan M, Tai VW, Abrams DI, Khatami H, Havel PJ, Sakkas G, Mulligan K
• Sarcopenia with limited mobility: an international consensus.
  Journal of the American Medical Directors Association 2011 Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Cederholm T, Coats AJ, Cummings SR, Evans WJ, Fearon K, Ferrucci L, Fielding RA, Guralnik JM, Harris TB, Inui A, Kalantar-Zadeh K, …
• Intensive glucose lowering and cardiovascular outcomes.
  The New England journal of medicine 2011 Winterstein AG, Heckbert SR, Schambelan M
• Insulin resistance in non-obese subjects is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle.
  PloS one 2011 Masharani UB, Maddux BA, Li X, Sakkas GK, Mulligan K, Schambelan M, Goldfine ID, Youngren JF
• Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement.
  PloS one 2011 Weinberg ME, Roman MC, Jacob P, Wen M, Cheung P, Walker UA, Mulligan K, Schambelan M
• Boosting dose ritonavir does not alter peripheral insulin sensitivity in healthy HIV-seronegative volunteers.
  Journal of acquired immune deficiency syndromes (1999) 2010 Taylor SA, Lee GA, Pao VY, Anthonypillai J, Aweeka FT, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C
• Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance.
  The Journal of clinical endocrinology and metabolism 2010 Rao MN, Mulligan K, Tai V, Wen MJ, Dyachenko A, Weinberg M, Li X, Lang T, Grunfeld C, Schwarz JM, Schambelan M
• A genome-wide association study of carotid atherosclerosis in HIV-infected men.
  AIDS (London, England) 2010 Shrestha S, Irvin MR, Taylor KD, Wiener HW, Pajewski NM, Haritunians T, Delaney JA, Schambelan M, Polak JF, Arnett DK, Chen YD, Grunfeld C
• The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers.
  AIDS (London, England) 2010 Pao VY, Lee GA, Taylor S, Aweeka FT, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C
• Can the use of creatine supplementation attenuate muscle loss in cachexia and wasting?
  Current opinion in clinical nutrition and metabolic care 2009 Sakkas GK, Schambelan M, Mulligan K
• Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost.
  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2009 Campos GM, Rabl C, Peeva S, Ciovica R, Rao M, Schwarz JM, Havel P, Schambelan M, Mulligan K
• The acute effects of HIV protease inhibitors on insulin suppression of glucose production in healthy HIV-negative men.
  Journal of acquired immune deficiency syndromes (1999) 2009 Lee GA, Schwarz JM, Patzek S, Kim S, Dyachenko A, Wen M, Mulligan K, Schambelan M, Grunfeld C
• Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled study.
  PloS one 2009 Sakkas GK, Mulligan K, Dasilva M, Doyle JW, Khatami H, Schleich T, Kent-Braun JA, Schambelan M
• The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.
  The Journal of clinical endocrinology and metabolism 2009 Mulligan K, Khatami H, Schwarz JM, Sakkas GK, DePaoli AM, Tai VW, Wen MJ, Lee GA, Grunfeld C, Schambelan M
• Development of appropriate coronary heart disease risk prediction models in HIV-infected patients.
  Circulation 2008 Schambelan M, Wilson PW, Yarasheski KE, Cade WT, Dávila-Román VG, D'Agostino RB, Helmy TA, Law M, Mondy KE, Nachman S, Peterson LR, Worm SW, Working Group 5
• State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary.
  Circulation 2008 Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dubé MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PW, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH
• Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers.
  AIDS (London, England) 2007 Lee GA, Rao M, Mulligan K, Lo JC, Aweeka F, Schwarz JM, Schambelan M, Grunfeld C
• Technical evaluation of in vivo abdominal fat and IMCL quantification using MRI and MRSI at 3 T.
  Magnetic resonance imaging 2007 Li X, Youngren JF, Hyun B, Sakkas GK, Mulligan K, Majumdar S, Masharani UB, Schambelan M, Goldfine ID
• Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
  The Journal of clinical endocrinology and metabolism 2006 Mulligan K, Zackin R, Von Roenn JH, Chesney MA, Egorin MJ, Sattler FR, Benson CA, Liu T, Umbleja T, Shriver S, Auchus RJ, Schambelan M, ACTG 313 Study Team
• Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006 Lee GA, Lo JC, Aweeka F, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C
• The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005 Lo JC, Kazemi MR, Hsue PY, Martin JN, Deeks SG, Schambelan M, Mulligan K
• Indinavir increases glucose production in healthy HIV-negative men.
  AIDS (London, England) 2004 Schwarz JM, Lee GA, Park S, Noor MA, Lee J, Wen M, Lo JC, Mulligan K, Schambelan M, Grunfeld C
• The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004 Lo JC, Mulligan K, Noor MA, Lee GA, Schwarz JM, Grunfeld C, Schambelan M
• HIV protease inhibitors increase adiponectin levels in HIV-negative men.
  Journal of acquired immune deficiency syndromes (1999) 2004 Lee GA, Mafong DD, Noor MA, Lo JC, Mulligan K, Schwarz JM, Schambelan M, Grunfeld C
• The metabolic effects of lopinavir/ritonavir in HIV-negative men.
  AIDS (London, England) 2004 Lee GA, Seneviratne T, Noor MA, Lo JC, Schwarz JM, Aweeka FT, Mulligan K, Schambelan M, Grunfeld C
• Time- and exercise-dependent gene regulation in human skeletal muscle.
  Genome biology 2003 Zambon AC, McDearmon EL, Salomonis N, Vranizan KM, Johansen KL, Adey D, Takahashi JS, Schambelan M, Conklin BR
• Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial.
  Annals of internal medicine 2003 Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M
• Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.
  Journal of acquired immune deficiency syndromes (1999) 2002 Schambelan M, Benson CA, Carr A, Currier JS, Dubé MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS, International AIDS Society-USA
• Effects of recombinant human growth hormone on fat distribution in patients with human immunodeficiency virus-associated wasting.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002 Tai VW, Schambelan M, Algren H, Shayevich C, Mulligan K
• Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting.
  International journal of cardiology 2002 Mulligan K, Schambelan M
• Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone.
  AIDS (London, England) 2002 Napolitano LA, Lo JC, Gotway MB, Mulligan K, Barbour JD, Schmidt D, Grant RM, Halvorsen RA, Schambelan M, McCune JM
• Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study.
  AIDS (London, England) 2002 Noor MA, Seneviratne T, Aweeka FT, Lo JC, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C
• Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation.
  The Journal of clinical endocrinology and metabolism 2002 Schwarz JM, Mulligan K, Lee J, Lo JC, Wen M, Noor MA, Grunfeld C, Schambelan M
• The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
  The Journal of clinical endocrinology and metabolism 2001 Lo JC, Mulligan K, Noor MA, Schwarz JM, Halvorsen RA, Grunfeld C, Schambelan M
• Reproductive function in human immunodeficiency virus infection.
  The Journal of clinical endocrinology and metabolism 2001 Lo JC, Schambelan M
• Metabolic effects of indinavir in healthy HIV-seronegative men.
  AIDS (London, England) 2001 Noor MA, Lo JC, Mulligan K, Schwarz JM, Halvorsen RA, Schambelan M, Grunfeld C
• Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy.
  Journal of acquired immune deficiency syndromes (1999) 2001 Mulligan K, Tai VW, Algren H, Abrams DI, Leiser RJ, Lo JC, Schambelan M
• Thalidomide for the treatment of AIDS-associated wasting.
  AIDS research and human retroviruses 2000 Kaplan G, Thomas S, Fierer DS, Mulligan K, Haslett PA, Fessel WJ, Smith LG, Kook KA, Stirling D, Schambelan M
• The tissue renin-angiotensin system in rats with fructose-induced hypertension: overexpression of type 1 angiotensin II receptor in adipose tissue.
  Journal of hypertension 2000 Giacchetti G, Sechi LA, Griffin CA, Don BR, Mantero F, Schambelan M
• Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection.
  Journal of acquired immune deficiency syndromes (1999) 2000 Mulligan K, Grunfeld C, Tai VW, Algren H, Pang M, Chernoff DN, Lo JC, Schambelan M
• Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
  Metabolism: clinical and experimental 1999 Khovidhunkit W, Memon RA, Shigenaga JK, Pang M, Schambelan M, Mulligan K, Feingold KR, Grunfeld C
• Use of growth hormone and other anabolic agents in AIDS wasting.
  JPEN. Journal of parenteral and enteral nutrition 1999 Mulligan K, Tai VW, Schambelan M
• Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
  JAMA 1999 Johansen KL, Mulligan K, Schambelan M
• The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease.
  Cell 1999 Westphal CH, Muller L, Zhou A, Zhu X, Bonner-Weir S, Schambelan M, Steiner DF, Lindberg I, Leder P
• Body shape changes in HIV-infected patients.
  Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998 Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M
• Effects of dietary gamma-linolenic acid on blood pressure and adrenal angiotensin receptors in hypertensive rats.
  Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1998 Engler MM, Schambelan M, Engler MB, Ball DL, Goodfriend TL
• Leptin, body composition, and indices of malnutrition in patients on dialysis.
  Journal of the American Society of Nephrology : JASN 1998 Johansen KL, Mulligan K, Tai V, Schambelan M
• Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting--a clinical research center study.
  The Journal of clinical endocrinology and metabolism 1998 Mulligan K, Tai VW, Schambelan M
• "Buffalo hump" in men with HIV-1 infection.
  Lancet (London, England) 1998 Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M
• Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats.
  American journal of hypertension 1997 Sechi LA, Griffin CA, Zingaro L, Catena C, De Carli S, Schambelan M, Bartoli E
• Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days.
  The Journal of infectious diseases 1997 Deeks SG, Coleman RL, White R, Pachl C, Schambelan M, Chernoff DN, Feinberg MB
• Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats.
  Diabetologia 1997 Sechi LA, Griffin CA, Zingaro L, Valentin JP, Bartoli E, Schambelan M
• Cross-sectional and longitudinal evaluation of body composition in men with HIV infection.
  Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997 Mulligan K, Tai VW, Schambelan M
• The renin-angiotensin system and compensatory renal hypertrophy in the rat.
  American journal of hypertension 1997 Valentin JP, Sechi LA, Griffin CA, Humphreys MH, Schambelan M
• Energy expenditure in human immunodeficiency virus infection.
  The New England journal of medicine 1997 Mulligan K, Tai VW, Schambelan M
• Ontogenic expression of renal and hepatic angiotensin II receptor genes in the rat.
  Nephron 1997 Griffin CA, Giacchetti G, Schambelan M, Sechi LA
• Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus.
  Diabetologia 1997 Sechi LA, Ceriello A, Griffin CA, Catena C, Amstad P, Schambelan M, Bartoli E
• Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.
  Annals of internal medicine 1996 Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB
• Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals.
  Proceedings of the National Academy of Sciences of the United States of America 1996 Meiner VL, Cases S, Myers HM, Sande ER, Bellosta S, Schambelan M, Pitas RE, McGuire J, Herz J, Farese RV
• Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat.
  Hypertension (Dallas, Tex. : 1979) 1996 Sechi LA, Griffin CA, Giacchetti G, Valentin JP, Llorens-Cortes C, Corvol P, Schambelan M
• Orthostatic hypertension due to vascular adrenergic hypersensitivity.
  Hypertension (Dallas, Tex. : 1979) 1996 Benowitz NL, Zevin S, Carlsen S, Wright J, Schambelan M, Cheitlin M
• Growth hormone replacement in healthy older men improves body composition but not functional ability.
  Annals of internal medicine 1996 Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M, Grunfeld C
• Abnormalities of insulin receptors in spontaneously hypertensive rats.
  Hypertension (Dallas, Tex. : 1979) 1996 Sechi LA, Griffin CA, Giacchetti G, Zingaro L, Catena C, Bartoli E, Schambelan M
• [Hyperaldosteronism sensitive to dexamethasone with adrenal adenoma. Clinical, biological and genetic study].
  Presse medicale (Paris, France : 1983) 1995 Jeunemaitre X, Charru A, Pascoe L, Guyene TT, Aupetit-Faisant B, Shackleton CH, Schambelan M, Plouin PF, Corvol P
• Receptors for atrial natriuretic peptide are decreased in the kidney of rats with streptozotocin-induced diabetes mellitus.
  The Journal of clinical investigation 1995 Sechi LA, Valentin JP, Griffin CA, Lee E, Bartoli E, Humphreys MH, Schambelan M
• Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel.
  Cell 1994 Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR, Ulick S, Milora RV, Findling JW
• The cardiac renin-angiotensin system in STZ-induced diabetes.
  Diabetes 1994 Sechi LA, Griffin CA, Schambelan M
• [Gene expression of the renin-angiotensin system in compensatory renal hypertrophy secondary to contralateral nephrectomy].
  Archives des maladies du coeur et des vaisseaux 1994 Valentin JP, Sechi LA, Griffin CA, Humphreys MH, Schambelan M
• Licorice ingestion and blood pressure regulating hormones.
  Steroids 1994 Schambelan M
• Effect of dietary sodium chloride on insulin receptor number and mRNA levels in rat kidney.
  The American journal of physiology 1994 Sechi LA, Griffin CA, Schambelan M
• Renin-angiotensin system gene expression during compensatory renal hypertrophy in the rat.
  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993 Valentin JP, Sechi LA, Griffin CA, Humphreys MH, Schambelan M
• The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat.
  Journal of the American Society of Nephrology : JASN 1993 Kalinyak JE, Sechi LA, Griffin CA, Don BR, Tavangar K, Kraemer FB, Hoffman AR, Schambelan M
• [Angiotensin II receptors in the heart conduction tissue].
  Minerva cardioangiologica 1993 Sechi LA, Griffin CA, De Carli S, Sechi G, Schambelan M, Bartoli E
• Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection.
  The Journal of clinical endocrinology and metabolism 1993 Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M
• [The role of G-regulatory proteins in the intracellular mechanism of cardiac angiotensin-II receptors].
  Cardiologia (Rome, Italy) 1993 Sechi LA, Sechi G, De Carli S, Griffin CA, Schambelan M, Bartoli E
• Autoradiographic characterization of angiotensin II receptor subtypes in rat intestine.
  The American journal of physiology 1993 Sechi LA, Valentin JP, Griffin CA, Schambelan M
• [Angiotensin receptors in the rat myocardium during pre- and postnatal development].
  Cardiologia (Rome, Italy) 1993 Sechi LA, Sechi G, De Carli S, Griffin CA, Schambelan M, Bartoli E
• Urodilatin binds to and activates renal receptors for atrial natriuretic peptide.
  Hypertension (Dallas, Tex. : 1979) 1993 Valentin JP, Sechi LA, Qui C, Schambelan M, Humphreys MH
• The endocrine complications of acquired immunodeficiency syndrome.
  Advances in internal medicine 1993 Masharani U, Schambelan M
• Characterization of angiotensin II receptor subtypes in rat heart.
  Circulation research 1992 Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M
• Plasma renin activity as a marker for growth failure due to sodium deficiency in young rats.
  Pediatric nephrology (Berlin, Germany) 1992 Ray PE, Schambelan M, Hintz R, Ruley EJ, Harrah J, Holliday MA
• Tissue-specific regulation of insulin receptor mRNA levels in rats with STZ-induced diabetes mellitus.
  Diabetes 1992 Sechi LA, Griffin CA, Grady EF, Grunfeld C, Kalinyak JE, Schambelan M
• An accurate practical method for estimating GFR in clinical studies using a constant subcutaneous infusion.
  Kidney international 1992 al-Uzri A, Holliday MA, Gambertoglio JG, Schambelan M, Kogan BA, Don BR
• Distribution of angiotensin II receptor subtypes in rat and human kidney.
  The American journal of physiology 1992 Sechi LA, Grady EF, Griffin CA, Kalinyak JE, Schambelan M
• Characterization of angiotensin II receptor subtypes in the rat kidney and heart using the non-peptide antagonists DuP 753 and PD 123 177.
  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991 Sechi LA, Grady EF, Griffin CA, Kalinyak JE, Schambelan M
• Insulin receptor concentration and gene expression are modulated by sodium intake in the rat kidney.
  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991 Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M
• Expression of AT2 receptors in the developing rat fetus.
  The Journal of clinical investigation 1991 Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE
• Hormonal mediators of amino acid-induced glomerular hyperfiltration in humans.
  The American journal of physiology 1991 Wada L, Don BR, Schambelan M
• Proteinuria, albumin synthesis and hyperlipidaemia in the nephrotic syndrome.
  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1991 Kaysen GA, Don B, Schambelan M
• The effect of angiotensin-converting enzyme inhibition and dietary protein restriction in the treatment of proteinuria.
  American journal of kidney diseases : the official journal of the National Kidney Foundation 1991 Don BR, Kaysen GA, Hutchison FN, Schambelan M
• Effects of renin inhibition in systemic hypertension.
  The American journal of cardiology 1990 Anderson PW, Do YS, Schambelan M, Horton R, Boger RS, Luther RR, Hsueh WA
• Hyperkalemia in acute glomerulonephritis due to transient hyporeninemic hypoaldosteronism.
  Kidney international 1990 Don BR, Schambelan M
• Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis.
  Annals of internal medicine 1990 Farese RV, Schambelan M, Hollander H, Stringari S, Jacobson MA
• Pseudohyperkalemia caused by fist clenching during phlebotomy.
  The New England journal of medicine 1990 Don BR, Sebastian A, Cheitlin M, Christiansen M, Schambelan M
• Effect of the circulating renin-angiotensin system on prolactin release in humans.
  The Journal of clinical endocrinology and metabolism 1990 Denolle T, Rohmer V, Saint-Adnré JP, Guyene TT, Galland F, Bigorgne JC, Schambelan M, Corvol P
• Effect of dietary protein restriction and angiotensin converting enzyme inhibition on protein metabolism in the nephrotic syndrome.
  Kidney international. Supplement 1989 Don BR, Wada L, Kaysen GA, Schambelan M
• Diabetic nephropathy: hemodynamic basis and implications for disease management.
  Annals of internal medicine 1989 Noth RH, Krolewski AS, Kaysen GA, Meyer TW, Schambelan M
• Dietary protein intake modulates glomerular eicosanoid production in the rat.
  The American journal of physiology 1989 Don BR, Blake S, Hutchison FN, Kaysen GA, Schambelan M
• Response of plasma prorenin and active renin to chronic and acute alterations of renin secretion in normal humans. Studies using a direct immunoradiometric assay.
  The Journal of clinical investigation 1989 Toffelmire EB, Slater K, Corvol P, Menard J, Schambelan M
• Abnormalities of glomerular eicosanoid metabolism in states of glomerular hyperfiltration.
  Advances in experimental medicine and biology 1989 Schambelan M, Don BR, Kaysen GA, Blake S
• Diabetes, dietary protein and glomerular hyperfiltration.
  The Western journal of medicine 1987 Don BR, Schambelan M
• Modulation of albuminuria by dietary protein and converting enzyme inhibition.
  The American journal of physiology 1987 Hutchinson FN, Schambelan M, Kaysen GA
• Renal hyperkalemia.
  Seminars in nephrology 1987 Sebastian A, Schambelan M
• Dietary NaCl determines severity of potassium depletion-induced metabolic alkalosis.
  Kidney international 1987 Hernandez RE, Schambelan M, Cogan MG, Colman J, Morris RC, Sebastian A
• Adrenocortical hormone secretory response to chronic NH4Cl-induced metabolic acidosis.
  The American journal of physiology 1987 Schambelan M, Sebastian A, Katuna BA, Arteaga E
• Dietary protein intake modulates glomerular eicosanoid production in nephrotic rats.
  Advances in prostaglandin, thromboxane, and leukotriene research 1987 Hutchison FN, Don BR, Kaysen GA, Blake S, Schambelan M
• Primary aldosteronism: changing concepts in diagnosis and management.
  American journal of surgery 1986 Lim RC, Nakayama DK, Biglieri EG, Schambelan M, Hunt TK
• Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus.
  The Journal of clinical investigation 1985 Schambelan M, Blake S, Sraer J, Bens M, Nivez MP, Wahbe F
• The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
  The Journal of clinical endocrinology and metabolism 1985 Kater CE, Biglieri EG, Rost CR, Schambelan M, Hirai J, Chang BC, Brust N
• [Type IV renal tubular acidosis: pathogenetic role of aldosterone deficiency and hyperkalemia].
  Nephrologie 1985 Schambelan M, Sebastian A
• Aldosterone-producing adrenocortical carcinoma. Preoperative recognition and course in three cases.
  Annals of internal medicine 1984 Arteaga E, Biglieri EG, Kater CE, Lopez JM, Schambelan M
• Amelioration of metabolic acidosis by dietary potassium restriction in hyperkalemic patients with chronic renal insufficiency.
  The Journal of laboratory and clinical medicine 1984 Maher T, Schambelan M, Kurtz I, Hulter HN, Jones JW, Sebastian A
• Amelioration of hyperchloremic acidosis with furosemide therapy in patients with chronic renal insufficiency and type 4 renal tubular acidosis.
  American journal of nephrology 1984 Sebastian A, Schambelan M, Sutton JM
• Acquired primary hypoaldosteronism due to an isolated zona glomerulosa defect.
  The New England journal of medicine 1983 Williams FA, Schambelan M, Biglieri EG, Carey RM
• Response of adenylate cyclase to parathyroid hormone and prostaglandins by human isolated glomeruli.
  The Journal of clinical endocrinology and metabolism 1983 Ardaillou N, Nivez MP, Schambelan M, Ardaillou R
• Effect of diet on plasma acid-base composition in normal humans.
  Kidney international 1983 Kurtz I, Maher T, Hulter HN, Schambelan M, Sebastian A
• Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism.
  Hypertension (Dallas, Tex. : 1979) 1983 Kater CE, Biglieri EG, Schambelan M, Arteaga E
• Clomiphene-responsive hypogonadism in sickle cell anemia.
  Annals of internal medicine 1983 Landefeld CS, Schambelan M, Kaplan SL, Embury SH
• Normotensive pheochromocytoma. Pharmacologic, paraneoplastic and anesthetic considerations.
  The Western journal of medicine 1983 Kirby BD, Ham J, Fairley HB, Benowitz N, Schambelan M
• Disorders of distal nephron function.
  The American journal of medicine 1982 Sebastian A, Hulter HN, Kurtz I, Maher T, Schambelan M
• Systemic and renal acid-base effects of chronic dietary potassium depletion in humans.
  Kidney international 1982 Jones JW, Sebastian A, Hulter HN, Schambelan M, Sutton JM, Biglieri EG
• Endocrine hypertension.
  Clinics in endocrinology and metabolism 1981 Biglieri EG, Schambelan M
• Renovascular hypertension.
  Clinics in endocrinology and metabolism 1981 Perloff D, Schambelan M
• Factors determining electrolyte excretion and renin secretion after closure of an arteriovenous fistula in the dog.
  The Journal of laboratory and clinical medicine 1981 Humphreys MH, Al-Bander H, Eneas JF, Schambelan M
• Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption.
  Kidney international 1981 Schambelan M, Sebastian A, Rector FC
• Hypertension and angiographic findings in necrotizing vasculitis.
  Annals of internal medicine 1981 White RH, Schambelan M
• Pseudohyperaldosteronism with renal tubular resistance to mineralocorticoid hormones.
  Transactions of the Association of American Physicians 1981 Rodriguez JA, Biglieri EG, Schambelan M
• Use of computed tomography in diagnosing the cause of primary aldosteronism.
  The New England journal of medicine 1980 White EA, Schambelan M, Rost CR, Biglieri EG, Moss AA, Korobkin M
• Effect of mineralocorticoid replacement therapy on renal acid-base homeostasis in adrenalectomized patients.
  Kidney international 1980 Sebastian A, Sutton JM, Hulter HN, Schambelan M, Poler SM
• Dihydroergotamine treatment for orthostatic hypotension from Vacor rodenticide.
  Annals of internal medicine 1980 Benowitz NL, Byrd R, Schambelan M, Rosenberg J, Roizen MF
• Hypertension, hyperreninemia, and secondary hyperaldosteronism in systemic necrotizing vasculitis.
  Annals of internal medicine 1980 White RH, Schambelan M
• Pathogenesis of renal hyperchloremic acidosis resulting from dietary potassium restriction in the dog: role of aldosterone.
  The American journal of physiology 1980 Hulter HN, Sebastian A, Sigala JF, Licht JH, Glynn RD, Schambelan M, Biglieri EG
• Clinical manifestation of adrenocorticotropin-determined plasma concentrations of mineralocorticoid hormones.
  Progress in biochemical pharmacology 1980 Biglieri EG, Brust N, Chang B, Hirai J, Wajchenberg BL, Schambelan M
• Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency.
  Kidney international 1980 Schambelan M, Sebastian A, Biglieri EG
• Adrenocorticotropin inhibition of mineralocorticoid hormone production.
  Clinical science (London, England : 1979) 1979 Biglieri EG, Chang B, Hirai J, Brust N, Rost CR, Schambelan M
• The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism.
  The Journal of clinical endocrinology and metabolism 1979 Biglieri EG, Schambelan M
• Hyporeninemic hypoaldosteronism.
  Advances in internal medicine 1979 Schambelan M, Sebastian A
• Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism.
  The New England journal of medicine 1977 Sebastian A, Schambelan M, Lindenfeld S, Morris RC
• Concurrent hypercortisolism and hypermineralocorticoidism.
  The American journal of medicine 1977 Hogan MJ, Schambelan M, Biglieri EG
• Treatment of high-renin hypertension with propranolol in children after renal transplantation.
  The Journal of pediatrics 1977 Potter DE, Schambelan M, Salvatierra O, Orloff S, Holliday MA
• Role of steroids in hypertension: evaluation of plasma mineralocorticoid activity with aldosterone receptors.
  Clinical science and molecular medicine. Supplement 1976 Baxter JD, Schambelan M, Matulich DT, Spindler BJ, Bartter FC
• Mineralocorticoid receptors in human kidney.
  The Journal of clinical endocrinology and metabolism 1976 Matulich DT, Spindler BJ, Schambelan M, Baxter JD
• Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.
  The Journal of clinical investigation 1976 Baxter JD, Schambelan M, Matulich DT, Spindler BJ, Taylor AA, Bartter FC
• Studies in a phenotypic female with 17-alpha-hydroxylase deficiency.
  The Journal of pediatrics 1976 Kershnar AK, Borut D, Kogut MD, Biglieri EG, Schambelan M
• Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism.
  The Journal of clinical endocrinology and metabolism 1976 Schambelan M, Brust NL, Chang BC, Slater KL, Biglieri EG
• Location of aldosterone-producing adenomas with 131I-19-iodocholesterol.
  The New England journal of medicine 1976 Hogan MJ, McRae J, Schambelan M, Biglieri EG
• Segmental renal vein sampling for renin.
  Radiology 1976 Korobkin M, Glickman MG, Schambelan M
• Selection of patients and operative approach in primary aldosteronism.
  Annals of surgery 1975 Hunt TK, Schambelan M, Biglieri EG
• Letter: Hyporeninemic hypoaldosteronism in chronic renal disease.
  Metabolism: clinical and experimental 1975 Schambelan M
• Clinical manifestations of adrenal hemorrhage.
  American journal of surgery 1974 Clark OH, Hall AD, Schambelan M
• Selective renal-vein renin sampling in hypertensive patients with segmental renal lesions.
  The New England journal of medicine 1974 Schambelan M, Glickman M, Stockigt JR, Biglieri EG
• Gonadotropin-secreting renal carcinoma.
  Cancer 1974 Golde DW, Schambelan M, Weintraub BD, Rosen SW
• Systemic lupus erythematosus with adrenal insufficiency.
  The American journal of medicine 1973 Eichner HL, Schambelan M, Biglieri EG
• Role of renin and aldosterone in hypertension due to a renin-secreting tumor.
  The American journal of medicine 1973 Schambelan M, Howes EL, Noakes CA, Biglieri EG
• Segmental renal-vein renin sampling for segmental renal infarction. Studies in a hypertensive patient.
  Annals of internal medicine 1973 Stockigt JR, Hertz P, Schambelan M, Biglieri EG
• Isolated hypoaldosteronism in adults. A renin-deficiency syndrome.
  The New England journal of medicine 1972 Schambelan M, Stockigt JR, Biglieri EG
• Renal-vein renin in various forms of renal hypertension.
  Lancet (London, England) 1972 Stockigt JR, Collins RD, Noakes CA, Schambelan M, Biglieri EG
• Adrenal mineralocorticoids causing hypertension.
  The American journal of medicine 1972 Biglieri EG, Stockigt JR, Schambelan M
• Deoxycorticosterone production and regulation in man.
  The Journal of clinical endocrinology and metabolism 1972 Schambelan M, Biglieri EG
• Mineralocorticoid production in hyperadrenocorticism. Role in pathogenesis of hypokalemic alkalosis.
  The American journal of medicine 1971 Schambelan M, Slaton PE, Biglieri EG
• A preliminary evaluation for primary aldosteronism.
  Archives of internal medicine 1970 Biglieri EG, Stockigt JR, Schambelan M
• The intercurrent hypertension of primary aldosteronism.
  Circulation research 1970 Biglieri EG, Schambelan M, Slaton PE, Stockigt JR
• Adrenal insufficiency and inappropriate secretion of antidiuretic hormone. Occurrence in a patient with carcinoma of the lung.
  Archives of internal medicine 1969 Schambelan M, Slaton PE, Murray JF, Biglieri EG
• Stimulation and suppression of aldosterone secretion in patients with an aldosterone-producing adenoma.
  The Journal of clinical endocrinology and metabolism 1969 Slaton PE, Schambelan M, Biglieri EG
• Hypermineralocorticoidism.
  The American journal of medicine 1968 Biglieri EG, Slaton PE, Schambelan M, Kronfield SJ
• Encephalitis and purpura with influenza infection. A case report.
  American journal of diseases of children (1960) 1966 Schambelan M, Sussman S